XML 28 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
OPERATING ACTIVITIES:    
Net income (loss) $ (73) $ 278
Adjustments to net income (loss):    
Depreciation, amortization, and accretion of AROs 337 318
Gain (loss) on disposal and sale of business interests 1 (43)
Impairment expense 49 46
Deferred income tax expense 10 222
Emissions Allowance Expense 102 47
Other 129 98
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (99) (232)
(Increase) decrease in inventory (28) 72
(Increase) decrease in prepaid expenses and other current assets 169 39
(Increase) decrease in other assets 18 (91)
Increase (decrease) in accounts payable and other current liabilities 3 (85)
Increase (decrease) in income tax payables, net and other tax payables (83) (327)
Increase (decrease) in other liabilities 25 18
Net cash provided by operating activities 545 287
INVESTING ACTIVITIES:    
Capital expenditures (1,254) (2,148)
Payments to Acquire Businesses and Interest in Affiliates 4 57
Proceeds from Divestiture of Businesses and Interests in Affiliates 5 11
Sale of short-term investments 33 141
Purchase of short-term investments (18) (144)
Contributions and loans to equity affiliates (1) (21)
Payments to Acquire Intangible Assets (39) (56)
Other investing (4) (112)
Net cash used in investing activities (1,282) (2,386)
FINANCING ACTIVITIES:    
Borrowings under the revolving credit facilities 1,187 1,741
Repayments under the revolving credit facilities (451) (1,037)
Proceeds from (Repayments of) Commercial Paper 255 719
Issuance of recourse debt 800 0
Repayments of recourse debt (774) 0
Issuance of non-recourse debt 1,293 2,131
Repayments of non-recourse debt (759) (915)
Payments for financing fees (21) (31)
Purchases under supplier financing arrangements (317) (486)
Repayments of obligations under supplier financing arrangements 628 516
Distributions to noncontrolling interests (84) (23)
Contributions from noncontrolling interests 73 26
Sales to Noncontrolling Interests 245 125
Dividends paid on AES common stock (125) (116)
Payments for financed capital expenditures (7) (7)
Other financing (4) 23
Net cash provided by financing activities 1,317 2,606
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1) (15)
Net Cash Change Of Discontinued And Held For Sale Businesses (52) 73
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 527 565
Cash, cash equivalents and restricted cash, beginning 2,039 1,990
Cash, cash equivalents and restricted cash, ending 2,566 2,555
SUPPLEMENTAL DISCLOSURES:    
Cash payments for interest, net of amounts capitalized 267 354
Cash payments for income taxes, net of refunds 60 68
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Noncash or Part Noncash Divestiture, Amount of Consideration Received 0 9
Lease Obligation Incurred 60 124
Conversion of Stock, Amount Converted 0 838
Non-cash contributions from noncontrolling interests 42 0
Dividends declared but not yet paid 125 116
Other current assets, net of $0 allowance for both periods 1,341  
Loss (gain) on realized/unrealized derivatives $ (15) $ (73)